These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8819352)

  • 21. Morphology and release kinetics of technetium-99m(V) dimercaptosuccinic acid loaded, poly(lactic-co-glycolic)acid microspheric delivery system. An experimental approach that may be used for targeted radiation treatment.
    Shukla J; Bandopadhyaya GP; Varma IK; Kumar R; Maulik SK
    Hell J Nucl Med; 2007; 10(1):9-13. PubMed ID: 17450243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Tc-99m (V) DMSA binding to human plasma proteins.
    Lee BF; Yeh JL; Chiu NT; Liu GC; Yu HS; Wang MH; Shen LH
    Kaohsiung J Med Sci; 2008 Jan; 24(1):1-9. PubMed ID: 18218563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An improved (99m)Tc-aprotinin kit formulation: quality control analysis of radiotracer stability and cold kit shelf life.
    Smyth DR; Tsopelas C
    Nucl Med Biol; 2005 Nov; 32(8):885-9. PubMed ID: 16253814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of 99mTc-succimer dosing in pediatric patients.
    Galbraith W; Nguyen A; Harrison DL; Chen X; Talley K
    J Nucl Med Technol; 2013 Jun; 41(2):81-4. PubMed ID: 23608072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidental visualization of hepatic hemangioma during Tc-99m (v) DMSA, Tl-201, and Tc-99m MDP imaging.
    Adalet I; Kocak M; Oguz H; Alagol F; Cantez S
    Clin Nucl Med; 1995 Dec; 20(12):1106-7. PubMed ID: 8674308
    [No Abstract]   [Full Text] [Related]  

  • 26. SPECT images using 99mTc(V)-DMS in lung metastasis of osteosarcoma.
    Ohta H; Tsuji T; Endo K; Fujita T; Konishi J; Kotoura Y; Yamamuro T
    Ann Nucl Med; 1989 Mar; 3(1):37-40. PubMed ID: 2561895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofibromatosis type I shown by Tc-99m (V) DMSA.
    Hirano T; Otake H; Shinozaki T; Watanabe H
    Clin Nucl Med; 1997 Aug; 22(8):573-4. PubMed ID: 9262916
    [No Abstract]   [Full Text] [Related]  

  • 28. Adsorption of technetium-99m [99mTc] in the sample loop of an HPLC injection valve.
    Millar AM
    J Pharm Biomed Anal; 1997 Aug; 15(12):1937-40. PubMed ID: 9278900
    [No Abstract]   [Full Text] [Related]  

  • 29. The pharmacokinetics and biodistribution of technetium-99m(V)dimercaptosuccinic acid in an animal tumor model.
    Watkinson JC; Allen SJ; Laws DE; Lazarus CR; Maisey MN; Clarke SE
    J Nucl Med; 1991 Jun; 32(6):1235-8. PubMed ID: 1646304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The development of new tumor imaging 99mTc (V)-DMS kit: preparation and labeling condition studies].
    Yomoda I; Horiuchi K; Hata N; Masuda H; Yokoyama A; Ogawa H; Nakazawa N; Ooi T
    Kaku Igaku; 1987 Jan; 24(1):77-82. PubMed ID: 3033361
    [No Abstract]   [Full Text] [Related]  

  • 31. Search for polynuclear pentavalent technetium complex of dimercaptosuccinic acid [Tc(V)-DMS] tumour localization mechanism. I. Medullary thyroid carcinoma animal model.
    Horiuchi K; Yomoda I; Ohta H; Endo K; Yokoyama A
    Eur J Nucl Med; 1991; 18(10):796-800. PubMed ID: 1660401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tc-99m DMSA (V) uptake in multiorgan amyloidosis.
    Bhatnagar A; Sahoo M; Nijhawan VS; Sawroop K; Mondal A
    Clin Nucl Med; 1996 Sep; 21(9):733-4. PubMed ID: 8879878
    [No Abstract]   [Full Text] [Related]  

  • 33. 188Rhenium(V)-dimercaptosuccinic acid loaded poly(lactic-co-glycolic)acid microspheres for targeted radiotherapy: production and effectivity.
    Shukla J; Bandopadhyaya GP; Varma IK
    Pharmazie; 2005 Aug; 60(8):583-7. PubMed ID: 16124400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals.
    Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC
    Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and in vivo evaluation of 90Y-meso-dimercaptosuccinic acid (90Y-DMSA) for possible therapeutic use: comparison with 99mTc-DMSA.
    Djokić D; Janković D; Nikolić N
    Cancer Biother Radiopharm; 2009 Feb; 24(1):129-36. PubMed ID: 19243255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tc-99m(V) DMSA accumulation in thyroid amyloidosis.
    Ohta H; Hatabu H; Endo K; Fujita T; Iida Y; Kasagi K; Konishi J; Kotoura H
    Clin Nucl Med; 1991 Oct; 16(10):778-9. PubMed ID: 1660389
    [No Abstract]   [Full Text] [Related]  

  • 37. Stability of the radiopharmaceutical [99mTc]DMSA: study of the ligand exchange reaction with [99Tc]EDTA.
    Garcia Muñoz M; Garcia Domenech R; Galvez Alvarez J; Moreno Frigols J
    Int J Appl Radiat Isot; 1983 Nov; 34(11):1505-8. PubMed ID: 6315599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rapid radiochemical purity testing method for 99mTc-tetrofosmin.
    Eggert LA; Dick MD; Mahoney DW; Olson JP; Werner GL; Hung JC
    J Nucl Med Technol; 2010 Jun; 38(2):81-4. PubMed ID: 20484182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paper chromatographic and paper elettrophoretic study of the solution chemistry of Tc-99m-methylendiphosphonate and of Tc-99m-dimercaptosuccinate for improving the tumour-affinity of Tc-99m during scintigraphic imaging of cancer.
    Shukla SK; Atzei G; Sedda AF; Rossi G; Cipriani C
    Ann Chim; 2004; 94(9-10):761-6. PubMed ID: 15506627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insight into the structure and stability of Tc and Re DMSA complexes: A computational study.
    Hernández-Valdés D; Blanco-González A; García-Fleitas A; Rodríguez-Riera Z; Meola G; Alberto R; Jáuregui-Haza U
    J Mol Graph Model; 2017 Jan; 71():167-175. PubMed ID: 27923180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.